InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Thompson Tamar. Officer active across 2 companies, notably Avidity Biosciences, Inc.. Cumulatively, 7 reports have been logged. Activity tracked since 7 October 2024. The latest transaction was filed on 15 July 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Thompson Tamar is a declarant and a Director at Avidity Biosciences, Inc. and Catalyst Pharmaceuticals, INC. The record shows 6 filings in total, with recent filings from 2024-10-09 to 2026-02-27; the modal transaction nature is option exercise.